Figure 3
Figure 3. Treatment of Jβ2/LFA-1 cells or T blasts with activating or blocking antibodies enhances α5β1 and does not reduce α4β1 adhesion and migration on fibronectin. Jβ2.7/LFA-1 cells (A) or T blasts (B) were treated with α4 or α5 blocking antibodies and the LFA-1 activating antibody CBR LFA-1/2 or neutral antibody TS2/4 or left untreated. Cells were allowed to adhere to fibronectin, unbound cells washed off, and bound cells quantified from 6 screens in triplicate. Amounts of bound cells and standard deviations are shown. (C) T blasts were treated as earlier and allowed to migrate over a fibronectin-coated filter for 1 hour. Migrated cells were quantified from 3 independent experiments. *P < .05.

Treatment of Jβ2/LFA-1 cells or T blasts with activating or blocking antibodies enhances α5β1 and does not reduce α4β1 adhesion and migration on fibronectin. Jβ2.7/LFA-1 cells (A) or T blasts (B) were treated with α4 or α5 blocking antibodies and the LFA-1 activating antibody CBR LFA-1/2 or neutral antibody TS2/4 or left untreated. Cells were allowed to adhere to fibronectin, unbound cells washed off, and bound cells quantified from 6 screens in triplicate. Amounts of bound cells and standard deviations are shown. (C) T blasts were treated as earlier and allowed to migrate over a fibronectin-coated filter for 1 hour. Migrated cells were quantified from 3 independent experiments. *P < .05.

Close Modal

or Create an Account

Close Modal
Close Modal